Option Ivcf
Payments companies reported to CMS as associated with Option Ivcf. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Option Ivcf, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Option Ivcf
These are the largest totals companies reported as associated with Option Ivcf. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Joseph Erinjeri | New York, NY | Vascular & Interventional Radiology | $57.72 |
| Ken Zhao | New York, NY | Surgery | $57.72 |
| Fourat Ridouani | New York, NY | Vascular & Interventional Radiology | $57.72 |
| Vlasios Sotirchos | New York, NY | Vascular & Interventional Radiology | $57.72 |
| Daniel Holzwanger | New York, NY | Vascular & Interventional Radiology | $45.80 |
| Benjamin May | New York, NY | Vascular & Interventional Radiology | $45.80 |
| Brian Currie | New York, NY | Vascular & Interventional Radiology | $45.79 |
| Christopher Harnain | New York, NY | Vascular & Interventional Radiology | $45.78 |
| Kimberly Scherer | New York, NY | Diagnostic Radiology | $45.78 |
| Bradley Pua | New York, NY | Vascular & Interventional Radiology | $41.50 |
Prescribed Option Ivcf?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.